Shanghai, June 23, 2017 – The ‘SAPA-GP 15th Annual Conference’, one of the most premier pharma conference organized by SAPA-GP (Sino-American Pharmaceutical Professionals Association), was held in Philadelphia, PA, USA from June 23 to 24. The conference attracted attendees from highly diverse backgrounds, including big pharma (Merck, GSK, J & J, Sanofi, Pfizer, AstraZeneca, Roche, Novartis, Amgen, Teva, etc.), biotech/CRO (WuXi AppTec, Alliance Pharma, Frontage Lab, etc.), as well as academic institutions (University of Pennsylvania, Columbia, Drexel, Temple, etc.).
Sundia VP, Dr. Russell Dahl was invited to be the panelist of the panel discussion on ‘US-China CRO landscape: Building Success with Strategic Alliances’ with the distinguished panelist including Dr. Henry Lu from Wuxi Apptec, Dr. Michelle Mack from Crown Bioscience and other executives.
Russell Dahl highlighted that Sundia, as a leading pre-clinical contract research organization (“CRO”), can also play a pivotal role in promoting R&D innovation and partnerships. Sundia has been recognized for its role as an important, long-term and innovative partner to global pharmaceutical and biotechnology companies throughout the drug discovery and development process. Through breakthrough discoveries and integrated solutions, Sundia has helped its partners accelerate innovation
Home
